Abstract Fine particulate matter< 2.5 μm (PM2. 5) air pollution is the most important
environmental risk factor contributing to global cardiovascular (CV) mortality and disability …

Ambient particulate matter (PM) pollution in China continues to be a major public health
challenge. With the release of the new WHO air quality guidelines in 2021, there is an urgent …

Background & Aims Accumulating animal studies have demonstrated the harmful
contribution of ambient air pollution (AP) to metabolic dysfunction-associated fatty liver …

The American Thoracic Society has previously published statements on what constitutes an
adverse effect on health of air pollution in 1985 and 2000. We set out to update and broaden …

Clinical and epidemiological studies demonstrate that short-and long-term exposure to air
pollution increases mortality due to respiratory and cardiovascular diseases. Given the …

Objective To study the effect of long term exposure to ambient fine particulate matter of
diameter≤ 2.5 μm (PM 2.5) on the incidence of total, ischemic, and hemorrhagic stroke …

Burgeoning epidemiological, animal, and cellular data link environmental endocrine-
disrupting chemicals (EDCs) to metabolic dysfunction. Disproportionate exposure to …

Objective Growing evidence indicates exposure to air pollution contributes to obesity and
cardiometabolic disease risk in children and adults, however studies are lacking in young …

Environmental persistent free radicals (EPFRs) are new environmental health risk
substances in the atmosphere, and their oxidative toxicity (OT) has not been strongly …

Abstract Fine particulate matter< 2.5 µm (PM2. 5) air pollution is a leading cause of global
morbidity and mortality. The largest portion of deaths is now known to be due to …